Predicting the optimal basal insulin infusion pattern in children and adolescents on insulin pumps

Paul-Martin Holterhus1, Jessica Bokelmann, Felix Riepe

  • 1Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics,Christian-Albrechts-University of Kiel, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany. holterhus@pediatrics.uni-kiel.de

Diabetes Care
|February 14, 2013
PubMed

Insights

This study identified four key basal insulin infusion patterns in children with type 1 diabetes on continuous subcutaneous insulin infusion therapy (CSII). These patterns help predict optimal insulin needs for better CSII management.

Area of Science:

  • Pediatric Endocrinology
  • Biomedical Engineering
  • Computational Biology

Background:

  • Type 1 diabetes (T1D) management in children requires precise insulin delivery.
  • Continuous subcutaneous insulin infusion (CSII) therapy offers a flexible approach to insulin management.
  • Understanding circadian basal insulin needs is crucial for optimizing CSII outcomes in pediatric patients.

Purpose of the Study:

  • To develop and cross-validate a mathematical model for predicting optimal basal insulin infusion patterns in children with T1D using CSII.
  • To identify distinct circadian basal rate (BR) patterns in a large cohort of pediatric CSII users.

Main Methods:

  • Utilized the German/Austrian DPV-Wiss database, analyzing data from 6,063 pediatric CSII patients (<20 years).
  • Employed unsupervised clustering to identify basal rate (BR) patterns and logistic regression to predict pattern probabilities.
  • Cross-validated the developed prediction model using independent datasets.

Main Results:

  • Identified four major circadian BR patterns in 5,903 (97.8%) of the analyzed patients.
  • The biphasic dawn-dusk pattern (BC) was prevalent in older children (mean age 12.8 years), while a single evening peak (F) was observed in younger children (mean age 6.3 years).
  • Age, diabetes duration, and sex were significant predictors of BR patterns; cross-validation showed high consistency for BC and F patterns.

Conclusions:

  • The reconfirmed four key BR patterns are realistic approximations of insulin needs in pediatric T1D patients on CSII.
  • A priori prediction of optimal basal insulin patterns can enhance CSII initiation and clinical management.
  • These identified patterns provide valuable data for advanced insulin-infusion algorithms in closed-loop CSII systems.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...